Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amide Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109111386A reveals a high-yield L-prolineamide synthesis. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101654416A details a scalable synthesis for anticancer intermediates, offering improved yields and safer processing compared to traditional nitro-reduction methods.
Patent CN100588646C details a scalable route for Aliskiren intermediates, eliminating toxic reagents and column chromatography for cost-effective manufacturing.
Patent CN101863954B details a high-yield route for Finasteride intermediates. Discover cost-effective manufacturing and scalable supply chain solutions for complex steroids.
Patent CN102816083B reveals high-purity Lacosamide intermediate synthesis with strict temperature control and improved yield for reliable supply chain.
Patent CN111253275A reveals a mild Cu-catalyzed N-demethylation method. Discover cost-effective synthesis routes for high-purity pharmaceutical intermediates.
Novel copper-catalyzed method for amide N-demethylation using NFSI. Offers mild conditions and high yields for API intermediates.
Patent CN114075137A reveals a high-yield synthesis route for nicosulfuron intermediates, offering significant supply chain stability and cost reduction benefits.
Advanced preparation method for Roflumilast intermediate ensuring high purity and scalable production for global pharmaceutical supply chains.
Patent CN101558056A details a selective halogenation process for anthranilamide intermediates, offering improved yield and scalability for pest control agent manufacturing.
Novel process using tri-n-propylamine improves yield and safety for ciprofloxacin intermediates. Cost-effective and scalable manufacturing solution.
Patent CN110615751A reveals a safer 2-oxothiopropionamide synthesis route. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Patent CN110669027B details novel tetrahydrofuran intermediates for prostate cancer drugs, offering streamlined synthesis and reduced manufacturing costs.
Patent CN110669027B discloses efficient synthesis of tetrahydrofuran carboxylic acid intermediates for prostate cancer drugs, offering scalable routes and reduced purification costs.
Patent CN114891838B reveals enzymatic resolution for dorzolamide intermediate. Achieve high purity and cost efficiency with scalable manufacturing processes.
Discover the patented purification method for 2-chloro-N-(2-chloro-4-methylpyridin-3-yl) nicotinamide. Achieve >99.9% purity with scalable, cost-effective crystallization.
Patent CN102675197A details a high-yield, eco-friendly route for Sorafenib intermediate. Reduces solvent use and improves purity for scalable manufacturing.
Patent CN105985292B enables mild asymmetric catalysis. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Patent CN106699605B offers a safe methylation method for lacosamide intermediates ensuring high purity and scalable production for reliable pharmaceutical supply chains.
Novel synthesis route for chlorantraniliprole intermediate ensures high purity and reduced waste for reliable agrochemical intermediate supply chains.